About
This clinical resource provides supplementary information for the Varicella-Zoster Immune Globulin Dose Calculator. It details the weight-based dosing, administration, and clinical context for VariZIG® (Varicella-Zoster Immune Globulin [Human]), which is used for post-exposure prophylaxis to reduce the severity of varicella (chickenpox) in high-risk individuals.
Outputs
The calculator provides the following key outputs based on the patient’s weight:
- Recommended Dose (IU): The total dose of VariZIG® in International Units, determined by the patient’s weight category.
- Number of Vials: The quantity of 125 IU vials required to prepare the recommended dose.
- Total Volume for Injection (mL): The final volume after reconstituting the required number of vials (each with 1.25 mL of diluent).
- Administration Summary: A concise instruction for intramuscular administration. It includes a warning if the total volume requires the dose to be split across multiple injection sites.
How to use
To use the calculator, follow these steps:
- Enter Patient Weight: Input the patient’s body weight into the designated field.
- Select Weight Unit: Choose the appropriate unit of measurement, either kilograms (kg) or pounds (lbs).
- Calculate: The tool automatically enables the calculate button once a valid weight is entered. The results are displayed instantly, showing the precise dosing regimen.
Dosing overview
VariZIG® is dosed according to body weight. The following table outlines the dosing schedule as per the manufacturer’s prescribing information.
| Weight Range | Dose | Vials |
|---|---|---|
| ≤ 10.0 kg | 125 IU | 1 |
| 10.1 kg to 20.0 kg | 250 IU | 2 |
| 20.1 kg to 30.0 kg | 375 IU | 3 |
| 30.1 kg to 40.0 kg | 500 IU | 4 |
| > 40.0 kg | 625 IU (Maximum) | 5 |
Administration: VariZIG® is for intramuscular (IM) injection only. The total volume should be divided if it exceeds site-specific limits (e.g., >3 mL for adults). Administer into the deltoid muscle or anterolateral aspect of the thigh.
Switching
The concept of “switching” therapies does not apply to Varicella-Zoster Immune Globulin. It is administered as a single-dose regimen for post-exposure prophylaxis following a specific exposure event and is not a long-term or maintenance therapy.
Missed dose
Optimal efficacy is achieved when VariZIG® is administered as soon as possible after a presumed exposure to the varicella-zoster virus. It should ideally be given within 96 hours (4 days). Administration may still provide benefit up to 10 days post-exposure. A “missed dose” is a failure to administer the product within this therapeutic window, which may reduce or eliminate its prophylactic benefit.
Safety alerts
Clinicians should be aware of the following safety information:
- For Intramuscular Use Only: Do not administer intravenously, as this can lead to severe systemic reactions.
- Injection Site: To avoid risk of sciatic nerve injury, do not administer in the gluteal region. Use the deltoid or anterolateral thigh muscles.
- Hypersensitivity: Allergic reactions, including anaphylaxis, are possible. Have appropriate medical treatment available.
- Thrombosis: Thromboembolic events have been associated with immune globulin products, although this is rare.
FAQ
What is the maximum recommended dose of VariZIG®?
The maximum recommended dose is 625 IU, which corresponds to 5 vials. This dose is used for all patients weighing over 40.0 kg.
How is a vial of VariZIG® reconstituted?
Each 125 IU vial of VariZIG® should be reconstituted with 1.25 mL of the supplied Sterile Diluent (Sterile Water for Injection, USP). This results in a final concentration of 100 IU/mL.
Can the total dose be administered in a single injection?
It depends on the total volume. Doses greater than 3 mL must be divided and administered at different IM injection sites. Smaller volumes may be required for children and infants based on muscle mass.
What is the therapeutic window for VZIG administration?
VZIG is most effective when given as soon as possible after exposure, preferably within 96 hours. However, it may still be administered up to 10 days post-exposure if necessary.
Does this calculator convert pounds to kilograms?
Yes, if you enter a patient’s weight in pounds (lbs), the tool automatically converts it to kilograms (kg) to apply the correct dosing schedule from the prescribing information.
Who is considered a high-risk individual for VZIG prophylaxis?
High-risk individuals include immunocompromised people without evidence of immunity, susceptible pregnant women, and newborns whose mothers have signs and symptoms of varicella around the time of delivery.
Does this tool determine the clinical indication for VZIG?
No. This tool is for dose calculation only. The decision to administer VZIG must be made by a qualified healthcare provider based on a full clinical assessment of the patient and the nature of the exposure.
What happens if a patient’s weight falls exactly on a threshold (e.g., 10.0 kg)?
The calculator applies the logic from the prescribing information. For example, a weight of up to and including 10.0 kg (≤ 10.0 kg) receives a dose of 125 IU. A weight of 10.1 kg falls into the next tier.
References
- VariZIG – U.S. Food and Drug Administration (FDA). Full prescribing information, reviews, and related documents.
- VariZIG® (Varicella Zoster Immune Globulin [Human]) Official HCP Site. Product information provided by the manufacturer, CSL Behring.
- CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book): Varicella. Chapter 22. Centers for Disease Control and Prevention.
- Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40.
I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com